Literature DB >> 10371195

Addressing substrate glutamine requirements for tissue transglutaminase using substance P analogues.

M T Pastor1, A Diez, E Pérez-Payá, C Abad.   

Abstract

We have investigated the effect on the substrate requirements for guinea pig liver (tissue) transglutaminase of a set of 11 synthetic glutamine substitution analogues making up the full sequence of the naturally occurring tissue transglutaminase substrate substance P. While a number of peptide sequences derived from proteins that are well-recognized as tissue transglutaminase substrates have been studied, the enzyme activity using substitution analogues of full-length natural substrates has not been investigated as thoroughly. Thus, our set of substance P analogues only differs from one to other by one amino acid mutation while the length (of the peptide) is maintained as in the natural parent peptide. Our results indicate that a glutamine residue is not recognized as substrate by the enzyme whether it is placed at the N- or C-terminal or between two positively charged residues or between two proline residues. To further address the effect on enzyme activity of charged amino acids in the vicinity of the reactive glutamine residue, a new set of synthetic charge replacement analogues of substance P has been also studied. Together, the results have identified new minimal requirements for modification of a particular glutamine residue in a polypeptide chain. It would be of interest to set up a full set of such requirements in order to highlight potential glutamine residues as enzyme targets in the growing list of proteins that are being described as transglutaminase substrates.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10371195     DOI: 10.1016/s0014-5793(99)00572-4

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  8 in total

1.  Reactivity of the N-terminal region of fibronectin protein to transglutaminase 2 and factor XIIIA.

Authors:  Brian R Hoffmann; Douglas S Annis; Deane F Mosher
Journal:  J Biol Chem       Date:  2011-07-11       Impact factor: 5.157

2.  Method for screening and MALDI-TOF MS sequencing of encoded combinatorial libraries.

Authors:  Bi-Huang Hu; Marsha Ritter Jones; Phillip B Messersmith
Journal:  Anal Chem       Date:  2007-08-23       Impact factor: 6.986

3.  Transglutaminase 2 inhibits Rb binding of human papillomavirus E7 by incorporating polyamine.

Authors:  Ju-Hong Jeon; Kyung-Ho Choi; Sung-Yup Cho; Chai-Wan Kim; Dong-Myung Shin; Joon-Cheol Kwon; Kye-Yong Song; Sang-Chul Park; In-Gyu Kim
Journal:  EMBO J       Date:  2003-10-01       Impact factor: 11.598

4.  Phage display selection of efficient glutamine-donor substrate peptides for transglutaminase 2.

Authors:  Zsolt Keresztessy; Eva Csosz; Jolán Hársfalvi; Krisztián Csomós; Joe Gray; Robert N Lightowlers; Jeremy H Lakey; Zoltán Balajthy; László Fésüs
Journal:  Protein Sci       Date:  2006-11       Impact factor: 6.725

Review 5.  Transglutaminases: nature's biological glues.

Authors:  Martin Griffin; Rita Casadio; Carlo M Bergamini
Journal:  Biochem J       Date:  2002-12-01       Impact factor: 3.857

6.  Heparan sulfate and transglutaminase activity are required for the formation of covalently cross-linked hedgehog oligomers.

Authors:  Tabea Dierker; Rita Dreier; Manuel Migone; Sabine Hamer; Kay Grobe
Journal:  J Biol Chem       Date:  2009-09-28       Impact factor: 5.157

7.  Specificity of tissue transglutaminase explains cereal toxicity in celiac disease.

Authors:  L Willemijn Vader; Arnoud de Ru; Yvonne van der Wal; Yvonne M C Kooy; Willemien Benckhuijsen; M Luisa Mearin; Jan Wouter Drijfhout; Peter van Veelen; Frits Koning
Journal:  J Exp Med       Date:  2002-03-04       Impact factor: 14.307

8.  Resolution of Eczema with Multivalent Peptides.

Authors:  Laura L Eggink; J Kenneth Hoober
Journal:  JID Innov       Date:  2022-07-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.